The human and murine MOK2 proteins are factors able to recognize both DNA and RNA through their zinc ®nger motifs. This dual af®nity of MOK2 suggests that MOK2 might be involved in transcription and post-transcriptional regulation of MOK2 target genes. The IRBP gene contains two MOK2-binding elements, a complete 18 bp MOK2-binding site located in intron 2 and the essential core MOK2-binding site (8 bp of conserved 3¢-half-site) located in the IRBP promoter. We have demonstrated that MOK2 can bind to the 8 bp present in the IRBP promoter and repress transcription from this promoter by competing with the CRX activator for DNA binding. In this study, we identify a novel interaction between lamin A/C and hsMOK2 by using the yeast two-hybrid system. The interaction, which was con®rmed by GST pull-down assays and co-immunolocalization studies in vivo, requires the N-terminal acidic domain of hsMOK2 and the coiled 2 domain of lamin A/C. Furthermore, we show that a fraction of hsMOK2 protein is associated with the nuclear matrix. We therefore suggest that hsMOK2 interactions with lamin A/C and the nuclear matrix may be important for its ability to repress transcription.
INTRODUCTION
The human and murine MOK2 orthologous genes, which are preferentially expressed in brain and testis tissues, encode two different Kru Èppel/TFIIIA-related zinc ®nger proteins (1, 2) . Although both proteins are clearly similar in that they contain seven tandem zinc ®nger motifs and a ®ve amino acid extension at their C-terminal ends, the human protein contains three additional tandemly arranged zinc ®nger motifs and a non-®nger acidic domain of 173 amino acids in its N-terminus. Alternative splicing of hsMOK2 also results in an isoform that contains a smaller N-terminal acidic domain of 76 amino acids (hsMOK2D).
The human and murine MOK2 proteins can recognize both DNA and RNA through their zinc ®nger motifs (3) . Electron microscopy and speci®c RNA homopolymer binding activity showed clearly that the murine and human MOK2 proteins are RNA-binding proteins that associate mainly with nuclear RNP components, including nucleoli and extranucleolar structures. The murine and human MOK2 proteins have been shown to bind the same 18 bp speci®c sequence in duplex DNA. Binding site selection with whole genomic PCR revealed that DNA-binding sites are localized in intron sequences. These results and the dual af®nity of MOK2 for RNA and DNA suggest that MOK2 may be involved in transcription and posttranscriptional regulation of MOK2 target genes. Our studies identi®ed eight putative hsMOK2 target genes, of which four, IRBP, PAX3, STEP and hRXRa (4±7), were already known. Initially, we showed that MOK2 negatively modulates expression of the interphotoreceptor retinoid-binding protein gene, IRBP (8) . IRBP is exclusively expressed in retinal photoreceptor cells and in a sub-group of pinealocytes, where it is thought to be involved in the visual cycle of the vertebrate retina (9±11). The IRBP gene contains two MOK2-binding elements, a complete 18 bp MOK2-binding site located in intron 2 and the essential core MOK2-binding site (8 bp of the conserved 3¢-half-site) located in the IRBP promoter. The results demonstrated that MOK2 could bind to the 8 bp sequence present in the IRBP promoter and repress transcription from this promoter, when transiently overexpressed in retinoblastoma Weri-RB1 cells. In the IRBP promoter, the TAAAGGCT MOK2-binding site overlaps with the photoreceptor-speci®c Crx-binding element (CRXE), suggesting that MOK2 represses transcription by competing with the cone±rod homeobox protein (CRX) for DNA binding and decreasing transcriptional activation through CRX. We have shown that Mok2 is expressed early in mouse embryonic development and in adult brain, suggesting that Mok2 might play an important role in development, and particularly in neuronal development.
The arrangement of the 8 bp essential core MOK2-binding site in the promoter and the 18 bp MOK2-binding site in the intron is reminiscent of that of another potential MOK2 target gene, Pax3. In this gene, the 18 bp MOK2-binding site is located in the last intron. A search for MOK2-binding sites in the proximal promoter region of human Pax3 reveals the presence of a TAAAAGGCT sequence that could possibly bind MOK2. Therefore, MOK2 might regulate the transcriptional activity of its target genes at different levels. One of the central questions regarding MOK2 relates to the mechanisms that control its dual binding activity. One model postulates that certain interaction partners of MOK2 might in¯uence its activity.
To identify the cellular proteins that interact with human hsMOK2, we employed the yeast two-hybrid system to screen a HeLa cDNA library. We identi®ed lamin A/C protein as a novel interaction partner of hsMOK2 and con®rmed the interaction through a variety of experimental methods. We demonstrate direct interaction between the N-terminal acidic domain of hsMOK2 and the coiled 2 domain of lamin A/C. This interaction can also take place in vivo in eukaryotic HeLa cells. Furthermore, we show that a signi®cant fraction of hsMOK2 protein is associated with the nuclear matrix.
MATERIALS AND METHODS

Plasmid constructs
All plasmids generated for this study were veri®ed by DNA sequencing. For the yeast two-hybrid assay, the full-length coding region of hsMOK2, the non-®nger acidic domain of hsMOK2 (nucleotides encoding amino acids 1±173) and the ®nger domain of hsMOK2 (nucleotides encoding amino acids 177± 458) were generated from the pBhsMOK2 vector (8) by PCR using 5¢ primers containing an EcoRI site and 3¢ primers containing a SalI site. After digestion with restriction enzyme, the three PCR products were cloned in-frame into the pLexA vector (BD Clontech) to generate, respectively, pLexhsMOK2, pLex-NH 2 and pLex-®nger fused to a LexA DNA binding domain.
A recombinant pGEX-DlaminC plasmid was obtained by inserting the blunt-ended XhoI±SmaI fragment of pGADDlaminC plasmid into SmaI-treated pGEX-2T (Amersham Pharmacia Biotech). The XhoI±SmaI fragment from pGADDlaminC contains nucleotides 516±1851 of lamin C cDNA (amino acids 128±572, accession no. M13451). pGEXlaminA/C-coil1BD (nucleotides encoding amino acids 128± 218), pGEX-laminA/C-coil2 (nucleotides encoding amino acids 243±387) and pGEX-laminA/C-tail (nucleotides encoding amino acids 384±566) were generated from pGEX-DlaminC by PCR using 5¢ primers and 3¢ primers containing a BamHI site and an EcoRI site, respectively. After digestion with EcoRI and BamHI, the products were cloned into the corresponding sites of the pGEX-3X vector (Amersham Pharmacia Biotech). The pCMV-GST-DlaminC vector was obtained by inserting the blunt-ended EcoRI fragment from pGEX-DlaminC into the pCMV-GST vector (12) digested by SmaI. The pBNH 2 hsMOK2 vector was obtained by inserting the BamHI±EcoRI fragment from pBhsMOK2 into the corresponding sites of the pBluescript KS + vector (Stratagene). The recombinant pCMV-GST-NH 2 hsMOK2 was obtained by inserting the blunt-ended EcoRI±SalI fragment of pLex-NH 2 into the PstI/DNA polymerase-treated pCMV-GST vector. The recombinant pCMV-hsMOK2 and pCMV-hsMOK2D vectors were previously described (3, 8) .
Yeast two-hybrid screen pLex-hsMOK2, pLex-NH 2 and pLex-®nger expression plasmids were transformed into the yeast L40 strain [MATa his3D200 trp1-901 leu2-3112 ade2 LYS2::(4lexAop-HIS3)-URA3::(8lexAop-lacZ)GAL4] using a standard lithium acetate transformation procedure. Plasmids were stably maintained by selection for the pLexA selection marker TRP1, which allows yeast growth in the absence of tryptophan. L40 yeast cells transformed with pLex-hsMOK2, pLex-NH 2 or pLex-®nger were then tested for activation of the reporter gene LacZ. pLex-hsMOK2 and pLex-®nger constructs alone or paired with the empty vector (pGAD-GH) did not activate the LacZ reporter gene. Very low activation of the LacZ reporter gene was detected with the pLex-NH 2 construct. A human HeLa S3 Matchmaker cDNA library (BD Clontech), constructed in the pGAD-GH vector expressing the GAL4 activation domain fusion protein, was transformed into L40 containing the pLexhsMOK2 construct. Transformants were selected by growing them on selective minimal media lacking histidine, leucine and tryptophan, but containing 10 mM 3-aminotriazole (3-AT) (Sigma) at 30°C for 4 days. Colonies that grew in this selective minimal media condition were scored for b-galactosidase activity by the ®lter assay method. Filters were incubated in b-galactosidase assay buffer at 30°C for 90 min. Bait loss was carried out by successive inoculation into media lacking leucine. Plasmids were isolated from positive colonies and transformed into Escherichia coli TG1 for plasmid ampli®-cation. The rescued pGAD plasmids containing the library inserts were transformed back into L40, either with the empty pLexA vector or with pLexA-hsMOK2, to verify that the interaction depended on the presence of both hsMOK2 and the candidate insert in pGAD-GH. The cDNA inserts were further characterized by sequencing them on an ABI sequence analyzer and searching for gene sequence similarity in the GenBankÔ database with the program BLAST.
Cell lines and antibodies
HeLa cells were grown in Dulbecco's modi®ed Eagle's minimal essential medium (DMEM) supplemented with 10% fetal calf serum. Af®nity puri®ed rabbit polyclonal antihsMOK2 antibody was obtained as described previously (8) . Mouse monoclonal anti-GST antibody clone 1D10 was purchased from Euromedex. Mouse monoclonal anti-lamin A/C(636) was purchased from Santa Cruz Biotechnology. Rhodamine (TRITC)-conjugated goat anti-mouse IgG, CY2Ô-conjugated goat anti-rabbit IgG, peroxidase-conjugated goat anti-rabbit IgG and peroxidase-conjugated goat antimouse IgG were purchased from Jackson Immunoresearch Laboratories.
Puri®cation of GST fusion proteins, in vitro protein synthesis and pull-down assay GST±Dlamin C, GST±lamin A/C coil1BD, GST±lamin A/C coil2 and GST±lamin A/C tail were produced in E.coli strain TG1. Protein expression was induced by adding 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 5 h at 30°C. GST fusion proteins were prepared as described by Frangioni and Neel (13) and puri®ed on glutathione±agarose gels (Sigma). The purity and quantity of the recombinant proteins were determined by examining SDS±PAGE gels stained with Coomassie blue. pBNH 2 hsMOK2 was translated in a 50 ml reaction of [ 35 S]Met/Cys (ICN) mixture using the TNT coupled transcription±translation system according to the manufacturer's instructions (Promega). An aliquot of the reaction was then resolved by SDS±PAGE to verify the quality of the synthesized product. For nuclear extracts, HeLa cells were plated at 10 6 cells on a 100 mm Petri dish for 24 h prior to transfection with 15 mg of recombinant plasmid by the calcium phosphate method as described previously (14) . Twenty-four hours after transfection, nuclear extracts were prepared according to Dignam (15) and dialyzed against buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 10 mM ZnSO 4 and 0.1% Nonidet P-40 at 4°C for 4 h. After dialysis and centrifugation, the nuclear extract was stored at ±80°C. The protein concentration was determined by the Coomassie blue protein assay (Pierce).
GST pull-down experiments were performed using 10 mg of GST fusion protein bound to glutathione beads and 10 ml of in vitro synthesized 35 S-labeled protein or 20 mg of nuclear proteins from transfected HeLa cells, in a total volume of 400 ml of binding buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 10 mM ZnSO 4 , 0.1% Nonidet P-40). After 4 h at 4°C, the beads were extensively washed with binding buffer, resuspended in SDS sample buffer (16) and separated by SDS±PAGE. The radiolabeled proteins were visualized by autoradiography after treatment with 16% sodium salicylate. Nuclear bound proteins from HeLa cells were analyzed by immunoblotting using the Supersignal West Pico Chemiluminescent Signal kit (Pierce). The binding was visualized by exposing the blots to Kodak BioMax MR ®lm.
Immuno¯uorescence microscopy
HeLa cells were plated at 10 5 cells on a 35 mm Petri dish containing a glass coverslip for 24 h prior to transfection with 2 mg of expression vector by the calcium phosphate method as described previously (14) . Twenty-four hours after transfection, the cells were ®xed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min and then permeabilized with 0.3% Triton X-100 in PBS for 15 min at room temperature (RT). Alternatively, cells were treated with ±20°C methanol for 3 min. The cells were incubated with the primary antibody anti-hsMOK2, anti-GST or anti-lamin A/C, followed by incubation with the secondary antibody. The incubations were done for 1 h each and were carried out sequentially (with washes in PBS after each step), as this gave optimal labeling. The cellular DNA was labeled with 0.05% 4,6-diamidino-2-phenylindole (DAPI). The slides were mounted in antifadent AF1/glycerol/PBS mounting medium (Citi¯uor Ltd, London, UK). Immuno¯uorescence microscopy was performed using a Leica DMR microscope (Leica, Heidelberg, Germany) and an APOCHROMAT 63 Q 1.32 oil immersion objective. Photographs were taken using a Micromax (Princeton Instruments) CCD camera and Metaview (Universal Imaging Corp.) software. For confocal analysis, images were sequentially collected by confocal laser scanning on a Leica TCS-NT/SP, equipped with an air-cooled argon±krypton mixed gas laser and an APOCHROMAT 63 Q 1.3 2 oil immersion objective. Z series were generated by collecting a stack consisting of 10±12 optical sections using a step size of 0.284 mm in the Z direction. Images were processed using Adobe Photoshop (Adobe Systems, Mountain View, CA).
Cellular fractionation and nuclear matrix isolation
For electrophoretic analysis, subcellular fractionation and nuclear matrix isolation were performed as described by Buckler-White et al. (17) with slight modi®cations. In brief, transfected HeLa cells were sequentially extracted with: 1% Triton X-100 in TMS buffer (50 mM Tris±HCl pH 7.4, 5 mM MgSO 4 , 250 mM sucrose) for 5 min at RT (fraction 1); 50 U/ml RNase-free DNase RQ1 (Promega) in TMS at 37°C for 30 min and adding ammonium sulfate to a ®nal concentration of 0.25 M (fraction 2); 2 M NaCl in TM buffer (10 mM Tris±HCl pH 7.4, 0.02 mM MgSO 4 ) twice for 15 min at RT (fraction 3); 50 mg/ml RNase A in TM for 15 min at RT (fraction 4). The ®nal pellet containing the nuclear matrix (fraction 5) was resuspended in SDS sample buffer (16) and boiled for 5 min. The protein concentrations were determined by the Amido Schwartz assay (18) and the proteins were separated by SDS±PAGE. hsMOK2 and truncated proteins were revealed by immunoblotting using the Supersignal West Pico Chemiluminescent Signal kit (Pierce). The blots were visualized using a Fluor-S Max MultiImager with Quantity One software (Bio-Rad).
For in situ fractionation, cells grown on polylysinecoated coverslips were washed three times with ice-cold PBS. After washing, the cells were sequentially extracted using the method described above with slight modi®cations. In these fractionation experiments, we used 0.5% Triton X-100 instead of 1% and added 0.5% Triton X-100 in all digestion buffers (TMS and TM) as described in the currently used protocol of He et al. (19) . For these experiments, the DNase treatment was done at RT. Monolayers of extracted cells at different steps of the nuclear matrix preparation were ®xed with ±20°C methanol for 3 min and then processed for indirect immuno¯uorescence microscopy as described above.
RESULTS
hsMOK2 interacts with lamin C in yeast
To identify interaction partners of hsMOK2 that might be involved in regulating hsMOK2 functions, we performed a two-hybrid yeast screen. We generated as bait a vector that expressed a fusion protein of the LexA binding domain and the full-length coding region of hsMOK2. The pLex-hsMOK2 plasmid did not autoactivate HIS3 or LacZ reporter genes upon transformation into L40 yeast. The pLex-hsMOK2 bait was used to screen a commercial human HeLa S3 Matchmaker cDNA library fused to the GaL4 activation domain in yeast L40 cells. After screening 5 Q 10 6 transformants, 43 yeast colonies that ®tted the criteria for interaction between bait and prey proteins (i.e. positive for both histidine growth and b-galactosidase activity) were obtained. The 43 clones were sequenced and the sequences were used to screen GenBank, which yielded nine unique sequences. Eight of these await further investigation. The ninth sequence encoded the C-terminal region of lamin C protein (amino acids 128±572; Fig. 1A ) and was selected for further study.
To determine which region of hsMOK2 interacts with lamin C, we co-transformed the library pGAD-DlaminC vector with pLex containing either one of the two different domains of hsMOK2, the non-®nger acidic domain (pLex-NH 2 ) or the ®nger domain (pLex-®nger) into the yeast strain L40 and again performed b-galactosidase assays. The results revealed that Dlamin C interacts only with the N-terminal acidic domain of hsMOK2 (Fig. 1B) . No interaction was found with the ®nger domain.
Interaction in vitro between the N-terminal acidic domain of hsMOK2 and the coiled 2 domain of lamin A/C GST pull-down experiments, employing full-length proteins and truncation mutants thereof, were conducted to verify the observations made in yeast and to map the respective interaction domains of hsMOK2 and lamin C. First, GST fused to Dlamin C (GST±Dlamin C, amino acids 128±572; Fig. 2A ) (20) was expressed in E.coli and immobilized on glutathione±agarose beads, which were then incubated with hsMOK2 transfected HeLa cell nuclear extracts. The results show that hsMOK2 speci®cally interacted with immobilized GST±Dlamin C but not with GST alone (Fig. 2B) . Next, GST fusion proteins containing different regions of lamin C were bound to glutathione±agarose beads and incubated with the in vitro translated 35 S-labeled N-terminal acidic domain of hsMOK2. Consistent with the yeast two-hybrid screen, the N-terminal domain of hsMOK2 was found to interact with Dlamin C (Fig. 2C) . As lamin C is identical to lamin A except for 6 amino acids at its C-terminus, the different regions used to locate the interaction domain are present in both proteins ( Figs 1A and 2A) . The coil 2 domain of lamin A/C, from amino acid 243 to 387, showed the same binding activity as Dlamin C (amino acids 128±572), while the coil 1BD domain (amino acids 128±218) and the tail domain (amino acids 384±566) showed no excess activity in comparison with the negative GST control (Fig. 2C) . Therefore, the coiled 2 domain of lamin A/C (amino acids 243±387) mediates hsMOK2 binding.
hsMOK2 and lamin A/C interact in vivo
To pursue the interaction between hsMOK2 and lamin A/C in vivo, we performed immuno¯uorescence studies in transfected HeLa cells. We chose to examine this question in transfected cells, because hsMOK2 protein is below the level required for detection by antibodies, as shown in Figures  3, 4 and 6, where any labeling was found in untransfected cells, and in Arranz et al. (3) . We previously demonstrated by in situ immunodetection and electron microscopy that endogenous human and murine MOK2 proteins are clearly localized in the nucleus (3). We ®rst examined the subcellular localization of hsMOK2 and compared it with that of lamin A/C. HeLa cells transfected with the expression vector CMVhsMOK2 were ®xed, permeabilized, stained with the relevant antibodies and then visualized by confocal laser microscopy. We obtained similar results when methanol was employed instead of paraformaldehyde for ®xation (data not shown). Staining of the cells with anti-lamin A/C antibody revealed staining of the nuclear periphery together with some staining of the nuclear interior (Fig. 3A, red) , as reported by others (21±23). As previously observed, hsMOK2 exhibits a homogeneous nuclear staining pattern in all transfected cells (Fig. 3A, green) . Expression of the N-terminal acidic domain of hsMOK2 showed both cytoplasmic and nuclear staining (Fig. 3B, green) . The small N-terminal acidic domain (21.7 kDa), which lacks a nuclear localization sequence, is probably passively distributed throughout the cytosol and the nucleus. To observe the effect of lamin A/C on the localization of the hsMOK2 protein or on the localization of the N-terminal acidic domain, the GST±Dlamin C expression vector was co-transfected into human HeLa cells. Co-transfection of hsMOK2 and GST±Dlamin C demonstrated a predominant staining of the nuclear periphery for hsMOK2 in the majority of the co-transfected cells as shown by the confocal overlays of the single section scanned in the same optical plane (Fig. 3C,  green) . This pattern was different from the nuclear distribution of hsMOK2 and suggested that the cellular localization of hsMOK2 changes in the presence of Dlamin C to a more Figure 1 . Identi®cation of lamin C as an interaction partner of hsMOK2 by the yeast two-hybrid system and identi®cation of the hsMOK2 interaction domain. (A) Schematic representation of human lamins A and C. Lamins A and C are identical in sequence except that lamin C has a unique 6 amino acid extension at its C-terminus (black box), while lamin A has a 98 amino acid extension (stripped box). Schematic representation of the pGADDlaminC library vector identi®ed from a HeLa cDNA library on the basis of its ability to activate the LacZ reporter gene in the presence of the LexA binding domain/hsMOK2 hybrid. (B) Constructs expressing full-length or the indicated domains of hsMOK2 and the human polypeptide Dlamin C were co-transformed into yeast. The speci®city of the interaction between bait and prey was determined by estimating the degree of color development after incubating the ®lter for 90 min in the ®lter lift b-galactosidase assay as described in Materials and Methods. +++, high blue color development; +/±, very low blue color development; ±, no color development. nuclear periphery distribution. Co-transfection of the N-terminal acidic domain of hsMOK2 and GST±Dlamin C did not appreciably change the cellular localization of this domain as shown by the confocal overlays of the single section scanned in the same optical plane (Fig. 3D) . To avoid the passive passage of the small N-terminal acidic domain into the nucleus, we fused it to GST in the eukaryotic expression vector CMV-GST. Expression of the small GST protein (27.9 kDa) showed a similar cytoplasmic and nuclear staining as observed with the small N-terminal acidic domain of hsMOK2 (Fig. 4A, green) . Transfection with the vector expressing GST±NH 2 hsMOK2 alone demonstrated a predominant cytoplasmic staining pattern in all transfected cells (Fig. 4B, green) , indicating that the large fusion protein (46.3 kDa) prevented passive diffusion of the NH 2 hsMOK2 domain and GST protein into the nucleus. Co-transfection with the vector expressing GST±NH 2 hsMOK2 with the vector expressing GST±Dlamin C substantially changed this exclusively cytoplasmic localization: in all co-transfected cells, GST±NH 2 hsMOK2 can be seen both in the nucleus and in the cytoplasm (Fig. 4C, green) . The changed localization of hsMOK2 and the nuclear translocation of GST±NH 2 hsMOK2 fusion proteins in the presence of GST±Dlamin C indicate that hsMOK2 and lamin A/C can also interact in living cells.
The transcription factor hsMOK2 is associated with the nuclear matrix Hozak et al. (22) showed that lamin A forms part of a diffuse skeleton throughout the nuclear interior in HeLa cells. We have shown previously by electron microscopy that the murine and human MOK2 proteins are mainly associated with nuclear RNP components, including nucleoli and extranucleolar structures. Previously, hnRNP proteins have been shown to be associated with the nuclear matrix (24) . These results suggest that MOK2 may bind to the nuclear matrix. To investigate this possibility, we isolated the nuclear matrix by sequential extraction of HeLa cells transfected with the eukaryotic expression vector CMV-hsMOK2, CMVhsMOK2D or CMV-NH 2 hsMOK2. In the ®rst fractionation step, soluble proteins are removed by extraction with 1% Triton X-100. Chromatin proteins are then released by DNase I digestion and extraction with 0.25 M ammonium sulfate. After washing with 2 M NaCl and RNase A digestion, the last fraction is composed of structural nuclear matrix proteins and nuclear matrix-associated proteins. Supernatants from each step and the ®nal nuclear matrix pellet were analyzed by SDS±PAGE and immunoblotting. The fractionation procedure was controlled by immunoblotting with antibody directed against lamin A/C, two nuclear matrix-associated proteins. In our extracts, lamin A and C proteins were detected as expected in the nuclear matrix fraction, but also in the high salt wash (Fig. 5A, lanes 3 and 5) . It has been observed that lamin A and C are not only found in nuclear lamina but also in the nucleoplasm (22, 25) . Lamin A and C released by 2 M NaCl in our fractionation protocol could correspond to lamin A and C present in the nucleoplasm. As shown in Figure 5A , a sizeable portion of hsMOK2 was released in the 1% Triton X-100 soluble fraction and the chromatin proteins while the remainder was tightly associated with the nuclear matrix proteins. No release of hsMOK2 was observed after RNase A treatment (Fig. 5A, lane 4) . These results suggest that the association of hsMOK2 with the nuclear matrix was independent of RNA components of the matrix that were accessible to RNase A digestion. Two times more hsMOK2D isoform truncated for the N-terminal acidic domain was detected in the nuclear matrix fraction while the majority of N-terminal acidic domain (~97%) was released in the Triton X-100 soluble fraction ( Fig. 5B and C) . These results suggest that the zinc ®nger domain is required for ef®cient targeting of hsMOK2 to the nuclear matrix. were incubated with an equal amount (10 mg) of GST or GST±Dlamin C bound to glutathione. Unbound (U) and bound (B) proteins were separated by SDS±PAGE and visualized by immunoblotting with af®nity puri®ed anti-hsMOK2 antibody. (C) In vitro 35 S-labeled NH 2 hsMOK2 was incubated with an equal amount (10 mg) of recombinant GST fusion proteins containing the full-length or one of the three different segments of lamin A/C or GST alone bound to glutathione beads. After thoroughly washing the beads, the bound proteins were eluted in SDS sample buffer, resolved by SDS±PAGE and visualized by autoradiography after treatment with 16% sodium salicylate.
To further investigate the association of hsMOK2 with the nuclear matrix, monolayers of HeLa cells transfected with hsMOK2 were submitted to in situ sequential fractionation. In these fractionation experiments, we have reduced the concentration of Triton X-100 to 0.5% as described in the currently used protocol of He et al. (19) because we lost too many cells when 1% Triton X-100 was used in the ®rst step. As seen in Figure 6 , a signi®cant fraction of hsMOK2 remained associated with the nuclear matrix structure after extraction with detergent (Fig. 6B) , DNase treatment and low salt wash (Fig. 6C) , 2 M high salt wash (Fig. 6D ) and RNase treatment (Fig. 6E) . The ef®ciency of chromatin digestion was indicated by the disappearance of the DAPI stain (Fig. 6C±E) , while the integrity of the nuclear matrix was veri®ed by lamin A/C antibody (Fig. 6A±E) . After DNA digestion and chromatin elution with 0.25 M ammonium sulfate, the residual structures were barely visible in phase contrast microscopy (not shown). The results obtained by these in situ fractionations con®rmed the results obtained by the above biochemical subcellular fractionations.
DISCUSSION
We used the yeast two-hybrid screen to identify novel protein partners for the transcription factor hsMOK2. Here, we present evidence to show that lamin C binds directly to the N-terminal acidic domain of hsMOK2. This interaction was con®rmed by GST pull-down assays, using both in vitro and in vivo produced hsMOK2. In mammalian somatic cells, there exist two major A-type lamins, termed lamins A and C, which are alternatively spliced products of the same gene. Both proteins are identical for the ®rst 566 amino acids, but contain unique C-terminal extensions after this common region (20, 26) . In lamin A, the C-terminal extension consists of 98 amino acids while in lamin C it comprises six residues (26). These isotypes are usually expressed in approximately equal amounts in differentiated somatic cells but their relative expression can differ in some tumors (27) . We demonstrated that the N-terminal acidic domain of hsMOK2 interacts with the region between amino acids 243 and 387 of lamin A/C. This small region corresponds to the coil 2 domain localized Figure 3 . Alteration of the subcellular localization of hsMOK2 by co-transfection with Dlamin C. HeLa cells were transfected with CMV-hsMOK2 (A) or CMV-NH 2 hsMOK2 (B) or co-transfected with CMV-hsMOK2 and CMV-GST-DlaminC (C) or CMV-NH 2 hsMOK2 and CMV-GST-DlaminC (D). Thirty-six hours after transfection, the cells were ®xed, permeabilized and double stained sequentially with anti-lamin A/C and anti-hsMOK2 antibodies (A and B) or with anti-GST and anti-hsMOK2 antibodies (C and D). Cells were examined by confocal scanning laser microscopy as described in Materials and Methods. Images correspond to a single confocal section though the middle of the nucleus scanned in the same optical plane. SS overlay corresponds to the single confocal section shown and MP overlay corresponds to maximum projection of all optical sections. In overlay, the co-localization of rhodamine-labeled and uorescein-labeled structures gives a yellow color. Bar, 10 mm.
within the C-terminal half of the central a-helical rod of lamin A/C (20). Thus, it is possible that both types of lamin can interact with hsMOK2 through an identical sequence present in the conserved coil 2 domain. Interestingly, the retinoblastoma (Rb) protein has also been found to bind to the coil 2 domain of lamin A/C (28), suggesting that the two different transcriptional repressor hsMOK2 and Rb factors compete for binding to the same small region of lamin A/C. Further, we showed that the physical interaction between hsMOK2 and lamin A/C can also take place in vivo in eukaryotic HeLa cells. The in vivo interaction between hsMOK2 and lamin A/C has been demonstrated by the change in nuclear localization of hsMOK2 and by the nuclear translocation of the N-terminal acidic domain observed in cells co-transfected with Dlamin C. Nuclear translocation of the N-terminal acidic domain of hsMOK2 showed that in vivo this domain is also responsible for lamin A/C binding. We have chosen to examine the in vivo interaction in transfected cells because the endogenous MOK2 proteins are dif®cult to assess due to the very low expression level. In order to visualize the endogenous MOK2 proteins and to improve the subnuclear localization, we have previously used in situ immunodetection and electron microscopy methods (3) . In human HeLa and murine L cells, which are only weakly labeled, we have found that the MOK2 proteins were associated with perichromatin ®brils and clusters of interchromatin granules, two structures involved in transcription and processing of pre-mRNA (29, 30) . We also showed that HeLa cells overexpressing human hsMOK2 protein did not exhibit any alteration in nuclear structure and that the general distribution of labeled nuclear RNP components was conserved (3). It has also been reported that lamin A co-localizes with RNP (21) . hnRNP proteins are known to be associated with the nuclear matrix (24) . These results suggest that MOK2 may bind to the nuclear matrix. Here, we have shown that a signi®cant fraction of hsMOK2 protein is associated with the nuclear matrix prepared from hsMOK2-transfected cells. Since RNase treatment did not affect the fraction of hsMOK2 associated with the nuclear matrix, we suspected that this attachment was independent of the hsMOK2 RNA binding property and instead involved protein±protein interactions. Lamins are major components of the nuclear matrix (31, 32) . A potential mechanism for tethering hsMOK2 to the nuclear matrix would be its interaction with the nuclear matrix structural protein lamin A/C. Our results suggest that the zinc ®nger domain of hsMOK2 is required for targeting to the nuclear matrix. This domain is different from the domain involved in lamin A/C binding. Therefore, the association of hsMOK2 with nuclear matrix might involve other proteins. Nuclear targeting requiring a zinc ®nger domain was also reported for the RNA-binding protein ZNF74 (33) . In contrast, the association of the transcription factors YY1 (34) and AKAP95 (35) with the nuclear matrix is independent of their zinc ®nger DNA-binding domains. Nuclear lamins were initially identi®ed as major components of the nuclear lamina which underlies the inner nuclear membrane (36, 37) . Actually, there is strong evidence that lamins are not restricted to the nuclear periphery. The nuclear lamins have also been found in the nucleoplasm and may be important constituents of the nucleoskeleton (21±23,38). It has been suggested that internal populations of lamin A and lamin C might anchor or organize components of the nuclear matrix (39) . An involvement of lamins A/C in transcription has been supported by the ®nding that Rb protein binds to lamins A/C in vivo and in vitro (28, 40, 41) . Our results also support an involvement of lamins A/C in transcription. MOK2 proteins recognize both DNA and RNA through their zinc ®nger motifs. This dual af®nity and the subnuclear localization of these proteins have suggested that MOK2 might play a role in transcription, as well as in posttranscriptional regulation processes, of its target genes. One of its target genes, the IRBP gene, contains two MOK2-binding elements, a complete 18 bp MOK2-binding site located in intron 2 and the essential core MOK2-binding site (8 bp of the conserved 3¢-half-site) located in the IRBP promoter. We have previously demonstrated that MOK2 can bind to the 8 bp present in the IRBP promoter and repress transcription from this promoter by competing with the activator CRX for DNA binding (8) . The particular arrangement of two MOK2-binding sites observed in the human IRBP and PAX3 genes suggests that hsMOK2 could repress transcription through different mechanisms. Actually, we do not know the role of the 18 bp MOK2-binding site present in intron 2 of IRBP. This site could allow MOK2 to repress transcription by blocking transcriptional elongation. Interestingly, it has been suggested that a negative regulatory element affecting mRNA elongation might be involved in controlling IRBP gene expression during fetal retinal development (42) . It is possible that the binding of hsMOK2 to one or two of these target sequences and its interaction with lamin A/C may be involved in the transcriptional repression of the IRBP gene through the formation of a speci®c highly ordered chromatin structure. This structural assembly may be associated with the nuclear lamina or the nuclear matrix and function as a global mechanism to repress transcription of hsMOK2 target genes. Figure 6 . Immunolocalization of hsMOK2 protein in transfected cells following in situ sequential fractionation. HeLa cells were transfected by CMV-hsMOK2 vector. Cells were untreated (A) or submitted to in situ sequential extraction with 0.5% Triton X-100 (B), DNase I at RT (C), 2 M NaCl (D) and RNase A (E) before ®xation. Double immunolabeling was performed as described in Materials and Methods using monoclonal antilamin A/C and polyclonal anti-hsMOK2 antibodies. All the immuno¯uores-cence photographs were acquired at the same exposure time. Images were printed at the same range of intensities for each color to facilitate comparisons except the image corresponding to untreated cells probed with antihsMOK2 antibody (A, green). At the same range of intensities, the image of untreated cells for hsMOK2 was saturated, which is consistent with the observation that a signi®cant fraction of hsMOK2 is released with soluble proteins in western blotting (Fig. 5A) . For each ®eld of cells analyzed, DAPI staining is shown. Bar, 10 mm.
